Dennis Kim
Overview
Dennis Kim received $2M in total compensation, including $273K in salary, at Cymabay Therapeutics in 2021. Dennis Kim also received $513K at Eleven Biotherapeutics in 2018.
Source: SEC filings on April 26, 2022 and April 30, 2019.
Related executives
We found 25 more executives who work or worked at Cymabay Therapeutics and Eleven Biotherapeutics.
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
Sujal Shah
Cymabay Therapeutics
Chief Executive Officer
Charles McWherter
Cymabay Therapeutics